NCAPD2 and neoplasm: Finally, a recent HotNet2 Pan-Cancer analysis suggested that multiple cancers harbor rare mutations in SMC2, SMC4, NCAPD2, NCAPD3, NCAPH2 and NCAPG2, supporting a tumor-suppressor role for condensin proteins (26).